We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Vanda Pharmaceuticals
VNDA
$302M
| $3.02M | ﹤0.01% |
200,871
-309
| -0.2% | -$5K |
|
1702
e.l.f. Beauty
ELF
$5.81B
| $3.01M | ﹤0.01% |
112,332
+60,562
| +117% | +$1.51M |
|
|
NTUS
1703
DELISTED
Natus Medical Inc
NTUS
| $3.01M | ﹤0.01% |
117,532
+1,585
| +1% | +$40.6K |
|
|
ALTR
1704
DELISTED
Altair Engineering Inc
ALTR
| $3.01M | ﹤0.01% |
48,038
-4,174
| -8% | -$255K |
|
1705
Zumiez
ZUMZ
$339M
| $3M | ﹤0.01% |
69,947
+689
| +1% | +$30.7K |
|
1706
Tenable Holdings
TENB
$4.01B
| $3M | ﹤0.01% |
82,841
-2,481
| -3% | -$112K |
|
1707
Orthofix Medical
OFIX
$419M
| $3M | ﹤0.01% |
69,144
-1,592
| -2% | -$70.2K |
|
1708
Lemonade
LMND
$4.1B
| $3M | ﹤0.01% |
32,165
+19,246
| +149% | +$2.49M |
|
|
PRSU
1709
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $2.99M | ﹤0.01% |
71,528
+1,214
| +2% | +$48.2K |
|
1710
Acadia Pharmaceuticals
ACAD
$5.03B
| $2.98M | ﹤0.01% |
115,682
-9,114
| -7% | -$401K |
|
|
ARGO
1711
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.98M | ﹤0.01% |
59,257
-3,983
| -6% | -$186K |
|
1712
Preferred Bank
PFBC
$1.25B
| $2.98M | ﹤0.01% |
46,820
-8,718
| -16% | -$493K |
|
|
CHCT
1713
Community Healthcare Trust
CHCT
$454M
| $2.98M | ﹤0.01% |
64,596
+1,635
| +3% | +$75.9K |
|
1714
JELD-WEN Holding
JELD
$164M
| $2.97M | ﹤0.01% |
107,273
-6,352
| -6% | -$176K |
|
1715
Banc of California
BANC
$2.97B
| $2.96M | ﹤0.01% |
163,592
+1,701
| +1% | +$31.6K |
|
1716
Clean Energy Fuels
CLNE
$347M
| $2.95M | ﹤0.01% |
214,692
-16,180
| -7% | -$207K |
|
1717
Andersons Inc
ANDE
$2.22B
| $2.94M | ﹤0.01% |
107,456
+1,888
| +2% | +$50K |
|
1718
John B. Sanfilippo & Son
JBSS
$972M
| $2.94M | ﹤0.01% |
32,526
+1,659
| +5% | +$144K |
|
1719
Cactus
WHD
$5.44B
| $2.94M | ﹤0.01% |
95,913
-6,728
| -7% | -$204K |
|
|
CHUY
1720
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.94M | ﹤0.01% |
66,246
+1,033
| +2% | +$39.7K |
|
|
HNGR
1721
DELISTED
Hanger Inc.
HNGR
| $2.94M | ﹤0.01% |
128,629
+4,022
| +3% | +$92.1K |
|
1722
Donnelley Financial Solutions
DFIN
$1.16B
| $2.93M | ﹤0.01% |
105,342
+351
| +0.3% | +$8.12K |
|
1723
Varex Imaging
VREX
$523M
| $2.92M | ﹤0.01% |
142,768
+567
| +0.4% | +$12.1K |
|
|
DOOR
1724
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.92M | ﹤0.01% |
25,353
-3,160
| -11% | -$343K |
|
1725
Albertsons Companies
ACI
$5.83B
| $2.92M | ﹤0.01% |
153,106
+107,549
| +236% | +$1.89M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.